Recce Ltd has released a press release.
Appendix 4E - Preliminary Final Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Recce Pharmaceuticals Ltd. on 6ix
Earlier from Recce Pharmaceuticals
- FDA Positive Response for Recce Scaled Manufacture & Quality
- Response to ASX Appendix 4C Query
- Key Family 2 Patent Granted in Europe for RECCE Antibiotics
- Opening R&D Address at World Antibiotic Resistance Congress
- Appendix 4C and commentary
Later from Recce Pharmaceuticals
- Funding Update
- Key Family 2 Patent Granted in Japan for RECCE Antibiotics
- Recce Completes Raising of $6.76 million
- Positive Data for RECCE 327 in MRSA Burns Wound Infection
- Positive Data from RECCE 327 Antibiotic Safety Studies
Follow Recce Pharmaceuticals into a list and get an email when it puts out news.
Follow Recce Pharmaceuticals